Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs HINDUSTAN BIOSCIE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MARKSANS PHARMA. HINDUSTAN BIOSCIE MARKSANS PHARMA./
HINDUSTAN BIOSCIE
 
P/E (TTM) x 21.5 265.4 8.1% View Chart
P/BV x 3.9 10.0 39.5% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 MARKSANS PHARMA.   HINDUSTAN BIOSCIE
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-23
HINDUSTAN BIOSCIE
Mar-23
MARKSANS PHARMA./
HINDUSTAN BIOSCIE
5-Yr Chart
Click to enlarge
High Rs746 1,328.9%   
Low Rs393 1,198.1%   
Sales per share (Unadj.) Rs40.90.9 4,543.8%  
Earnings per share (Unadj.) Rs5.90 -15,003.2%  
Cash flow per share (Unadj.) Rs7.00 -20,497.5%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs38.50.7 5,284.3%  
Shares outstanding (eoy) m453.1610.25 4,421.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.44.9 28.2%   
Avg P/E ratio x9.7-111.7 -8.6%  
P/CF ratio (eoy) x8.1-130.2 -6.2%  
Price / Book Value ratio x1.56.1 24.2%  
Dividend payout %8.50-   
Avg Mkt Cap Rs m25,63145 56,633.6%   
No. of employees `000NANA-   
Total wages/salary Rs m2,3942 133,726.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m18,5219 200,882.8%  
Other income Rs m5930-   
Total revenues Rs m19,1159 207,315.8%   
Gross profit Rs m3,3930 -1,211,860.7%  
Depreciation Rs m5190 864,216.7%   
Interest Rs m910 228,200.0%   
Profit before tax Rs m3,3770 -888,560.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7230 2,411,066.7%   
Profit after tax Rs m2,6530 -663,302.5%  
Gross profit margin %18.3-3.1 -599.2%  
Effective tax rate %21.4-6.6 -325.6%   
Net profit margin %14.3-4.4 -326.5%  
BALANCE SHEET DATA
Current assets Rs m16,9979 197,635.6%   
Current liabilities Rs m3,65414 25,765.5%   
Net working cap to sales %72.0-60.6 -119.0%  
Current ratio x4.70.6 767.1%  
Inventory Days Days6946 0.6%  
Debtors Days Days82179,564,165 0.0%  
Net fixed assets Rs m5,24624 21,640.8%   
Share capital Rs m45321 2,210.5%   
"Free" reserves Rs m16,998-13 -130,356.3%   
Net worth Rs m17,4527 233,622.8%   
Long term debt Rs m011 0.0%   
Total assets Rs m22,24233 67,729.5%  
Interest coverage x38.0-8.5 -447.0%   
Debt to equity ratio x01.5 0.0%  
Sales to assets ratio x0.80.3 296.6%   
Return on assets %12.3-1.1 -1,114.8%  
Return on equity %15.2-5.4 -280.8%  
Return on capital %19.9-1.8 -1,097.2%  
Exports to sales %00-   
Imports to sales %7.30-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m1,348NA-   
Fx inflow Rs m6,4916 110,586.7%   
Fx outflow Rs m1,3480-   
Net fx Rs m5,1436 87,615.7%   
CASH FLOW
From Operations Rs m2,374-1 -474,824.0%  
From Investments Rs m-2,592NA-  
From Financial Activity Rs m1,9781 395,658.0%  
Net Cashflow Rs m1,7600-  

Share Holding

Indian Promoters % 43.9 12.2 359.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 20.3 0.0 -  
FIIs % 15.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 56.2 87.8 63.9%  
Shareholders   237,377 10,315 2,301.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MARKSANS PHARMA. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on MARKSANS PHARMA. vs HINDUSTAN BIOSCIE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MARKSANS PHARMA. vs HINDUSTAN BIOSCIE Share Price Performance

Period MARKSANS PHARMA. HINDUSTAN BIOSCIE S&P BSE HEALTHCARE
1-Day 0.46% -1.89% 1.18%
1-Month -0.72% -24.16% -0.75%
1-Year 109.61% -13.38% 61.82%
3-Year CAGR 45.11% 34.35% 18.16%
5-Year CAGR 43.62% 50.47% 19.79%

* Compound Annual Growth Rate

Here are more details on the MARKSANS PHARMA. share price and the HINDUSTAN BIOSCIE share price.

Moving on to shareholding structures...

The promoters of MARKSANS PHARMA. hold a 43.9% stake in the company. In case of HINDUSTAN BIOSCIE the stake stands at 12.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MARKSANS PHARMA. and the shareholding pattern of HINDUSTAN BIOSCIE.

Finally, a word on dividends...

In the most recent financial year, MARKSANS PHARMA. paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 8.5%.

HINDUSTAN BIOSCIE paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of MARKSANS PHARMA., and the dividend history of HINDUSTAN BIOSCIE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.